Abstract: Both big (BK Ca ) and small (SK Ca ) conductance Ca 2+ -sensitive K + channels are present in mammalian cardiac cell mitochondria (m). We used pharmacological agonists and antagonists of BK Ca and SK Ca channels to examine the importance of endogenous opening of these channels and the relative contribution of either or both of these channels to protect against contractile dysfunction and reduce infarct size after ischemia reperfusion (IR) injury through a mitochondrial protective mechanism. After global cardiac IR injury of ex vivo perfused Guinea pig hearts, we found the following: both agonists NS1619 (for BK Ca ) and DCEB (for SK Ca ) improved contractility; BK Ca antagonist paxilline (PAX) alone or with SK Ca antagonist NS8593 worsened contractility and enhanced infarct size; both antagonists PAX and NS8593 obliterated protection by their respective agonists; BK Ca and SK Ca antagonists did not block protection afforded by SK Ca and BK Ca agonists, respectively; and all protective effects by the agonists were blocked by scavenging superoxide anions (O 2 $2 ) with Mn(III) tetrakis (4-benzoic acid) porphyrin (TBAP). Contractile function was inversely associated with global infarct size. In in vivo rats, infusion of NS8593, PAX, or both antagonists enhanced regional infarct size while infusion of either NS1619 or DCEB reduced infarct size. In cardiac mitochondria isolated from ex vivo hearts after IR, combined SK Ca and BK Ca agonists improved respiratory control index and Ca 2+ retention capacity compared with IR alone, whereas the combined antagonists did not alter respiratory control index but worsened Ca 2+ retention capacity. Although the differential protective bioenergetics effects of endogenous or exogenous BK Ca and SK Ca channel opening remain unclear, each channel likely responds to different sensing Ca 2+ concentrations and voltage gradients over time during oxidative stress-induced injury to individually or together protect cardiac mitochondria and myocytes.
INTRODUCTION
Altered mitochondrial (m) bioenergetics, excess reactive oxygen species (ROS) emission, and excess mCa 2+ overload are major factors that underlie ischemia reperfusion (IR) injury. 1 Prophylactic measures targeted to mitochondria that reduce cardiac IR injury 2, 3 include ischemic preconditioning (ie, brief pulses of ischemia and reperfusion before longer index ischemia) and pharmacologic preconditioning (PPC), ie, cardiac protection elicited some time after the drug is washed out before index IR. Drugs that reduce cardiac metabolism or mitochondrial bioenergetics when given before and/ or after IR also afford protection.
The induction of mitochondrial mK + influx is now recognized as an important underlying mechanism to reduce IR injury. We reported previously that activation by NS1619 of the large (big) conductance Ca 2+ -sensitive K + channel (BK Ca , K Ca 1.1, maxi-K), which is found in the cardiac myocyte inner mitochondrial membrane (IMM), induced PPC and that this protection was blocked by the mitochondrial-targeted superoxide anion (O 2 $2 ) scavenger Mn(III) tetrakis (4-benzoic acid) porphyrin (TBAP). 4 We subsequently reported that NS1619 had biphasic effects on mitochondrial respiration, membrane potential (DC m ), and O 2 $2 emission in isolated mitochondria. 5, 6 Due to our findings and many other reports on the protective effects of BK Ca and putative K ATP channel agonists in mitochondria, it is likely that opening of other mK + channels might also be protective but rely on different ligands and conditions for activation.
K Ca channels of intermediate or small conductance were first identified in noncardiac cells [7] [8] [9] [10] as membrane bound, calmodulin (CaM)-dependent and activated by Ca 2+ . These channels have smaller unit conductances of 3-30 (small, SK Ca ) and 20-90 (intermediate IK Ca ) pS. 11 The opening of SK Ca channels is initiated by Ca 2+ binding to calmodulin within the C terminus of the channel to form a dimer. 12, 13 Of the 4 known genes encoding SK Ca channel proteins, one of these, the K Ca 2.3 (aka SK3) isoform, was found in vascular endothelial cell membranes, where it exerted a potent, tonic hyperpolarization that promoted reduced vascular smooth muscle tone. 14 Later, the isoform K Ca 2.2 (aka SK2) was found in rat and human heart cell sarcolemma membranes by Western blot and RT-PCR. 15 Amplification of the channel from total atrial and ventricular RNA showed much greater expression in atria than in ventricles, and electrophysiological recordings exhibited much greater atrial than ventricular sensitivity to AP repolarization by apamin, a selective SK Ca antagonist. 15 , 16 Dolga et al 17 found that the SK2 channel was expressed also in mitochondria of neuronal HT-22 cells. At the same time, we furnished the first evidence for the presence of SK2 and SK3 isoforms in the IMM of Guinea pig cardiac mitochondria. 18 We tested the functionality of SK Ca channel opening 18 by perfusing isolated hearts transiently before ischemia with the K Ca 3.1 (IK Ca 1) 7, 9, 19 and K Ca 2.2 and K Ca 2.3 [20] [21] [22] [23] opener DCEBIO (DCEB). We found 18 that DCEB elicited PPC in a manner similar to that of the BK Ca channel agonist NS1619. 4 Either the SK Ca antagonist NS8593 24, 25 or TBAP, which dismutates O 2 $2 to H 2 O 2 , abolished the cardioprotection. 18 DCEB also reduced the deleterious effects of IR injury on mitochondrial bioenergetics by attenuating cardiac mitochondrial Ca 2+ overload and O 2 $2 levels, and by preserving (more reduced redox state) cardiac mitochondrial nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FAD) levels after IR. 18 These studies established that K Ca channel opening initiates a cascade of O 2 $2 -dependent cardiac protective mechanisms that are based primarily in cardiac myocyte mitochondria. In a recent extension of this research, 26 we: (1) confirmed SK Ca protein localization in cardiac ventricular mitochondria of rats and humans, in addition to Guinea pigs; (2) identified mitochondrial splice variants of SK3 in Guinea pig and human cardiac mitochondria; and (3) found that overexpression or silencing of SK3 reduced or enhanced, respectively, stress-induced damage in 2 cardiac cell lines, HL-1 and H9c2.
Our aim in this study was to determine whether endogenous opening of the BK Ca and/or SK Ca channel protected hearts and mitochondria from IR injury and if there were differential or additive cardioprotective effects of drug-induced opening of BK Ca and SK Ca channels. To test this, we (1) conducted a pharmacological comparison of SK Ca and BK Ca agonists and antagonists given before and after ischemia on global ventricular infarct size and developed left ventricular pressure (LVP) in isolated ex vivo perfused Guinea pig hearts; (2) examined the effect of SK Ca and BK Ca agonists and antagonists on regional infarct size when infused in rats in vivo; (3) assessed the role of mitochondrial-targeted O 2 $2 scavenging by TBAP to block protection by the 2 agonists; and (4) measured respiratory control index (RCI) and Ca 2+ retention capacity (CRC) after IR injury to further assess the likely role of mitochondria in protecting or impairing cardiac function and damage by treating ex vivo perfused hearts with SK Ca and BK Ca agonists or antagonists before and after IR injury.
MATERIALS AND METHODS

Function and Infarction in Ex Vivo Guinea Pig Hearts After Global IR Injury
The investigation conformed to the Guide for the Care and Use of Laboratory Animals (NIH Publication 85-23, revised 1996); all animal protocols were reviewed and approved by the Medical College of Wisconsin Institutional Animal Care and Use Committee. The hearts of adult Guinea pigs of either sex were isolated and prepared as described previously in detail. 4, 18, [27] [28] [29] [30] [31] [32] [33] Guinea pig hearts were chosen because of their more human-like cardiac action potentials and ion currents compared with rats. 34 In brief, animals were injected intraperitoneally with heparin (1000 units) and ketamine (50 mg/kg). Once anesthetized, thoracotomy was performed, hearts were excised, and their aortas immediately perfused in retrograde manner with a cold modified KrebsRinger's (KR) perfusate. After aortic cannulation, hearts were transferred to a Langendorff perfusion setup and instrumented with a saline filled balloon and transducer to measure isovolumetric, developed (systolic-diastolic) LVP and perfused at a constant aortic root pressure of 55 mm Hg with the KR solution at 378C. Heart rate was measured from right atrial and ventricular recording electrodes, and coronary (aortic) flow was measured with a flow transducer. Hearts were subjected to 35 minutes of global ischemia and 120 minutes of reperfusion; hearts not used for mitochondrial isolation were stained with 2,3,5-triphenyltetrazolium chloride (TTC) and infarct size was determined as a percentage of total ventricular heart weight. 4, 18, 28, 32 Infarct size measurements were blinded to the drug administered.
Isolated Guinea pig hearts (18 groups of 6-8 hearts each) were perfused with no drugs (control) or test drugs, ie, BK Ca or SK Ca agonists or antagonists, or TBAP alone or in combination, before and after the 35-minute period of global ischemia. Time control (TC) experiments were also conducted, ie, perfusion of isolated hearts with vehicle (DMSO) but without drugs or IR for the duration of the IR protocol. TC (no IR) functional variables decreased less than 5% over a 2.5-hour period. To assess endogenous cardioprotection mediated by IR-induced BK Ca and SK Ca channel activation, antagonists were given beginning 20 minutes before ischemia. To assess exogenous BK Ca and/ or SK Ca activation, agonists were given beginning 15 minutes before ischemia; all drugs were discontinued 20 minutes after the onset of reperfusion. Functional variables for display in figures were recorded at 25 minutes before ischemia (baseline) and at 120 minutes of reperfusion. Concentrations of drugs were gauged to elicit maximal effects as reported in the literature. [35] [36] [37] [38] Drugs were dissolved in less than 0.1% DMSO in KR buffer (vehicle) and perfused into isolated hearts. They were 3 mM DCEBIO (DCEB), a nonselective K Ca 2.2 and K Ca 2.3 channel agonist 7,20-23 ; 10 mM NS8593, a specific antagonist of SK Ca channels 24, 25 
Infarction in In Vivo Rat Hearts After Regional IR Injury
Adult Sprague Dawley rats (250-300 g) of either sex were anesthetized with inactin 150 mg/kg i.p., intubated, and artificial respiration was initiated. The right carotid artery was cannulated to monitor blood pressure continuously. After thoracotomy, a suture was placed around the proximal left anterior descending (LAD) artery to induce reversible coronary artery occlusion verified by regional epicardial cyanosis. Rats were chosen because the areaat-risk for cardiac infarction is more uniform than in Guinea pigs. 40 Hearts (6 groups of 4 each) were subjected to 35 minutes LAD occlusion by tightening the suture; releasing the suture was followed by 120 minutes of reperfusion. Other hearts had the suture placed around the LAD but not tightened [ [35] [36] [37] [38] PAX and NS8593, the antagonists for the BK Ca and SK Ca channels, respectively, were also perfused together to assess for any additive damaging effects. Drugs were infused 20 minutes before regional ischemia and for 20 minutes after release of the LAD occlusion. Infarct size measurements were blinded to the drug administered.
Respiration and CRC in Mitochondria Isolated After Global IR Injury
Ex vivo Guinea pig hearts were subjected to global ischemia with or without drug treatment as described above. At 20 minutes of reperfusion, some hearts (6 groups of approximately 5 each) that were not used to measure infarct size were removed from the perfusion apparatus and the ventricles were minced in cold mitochondrial isolation buffer on ice. Mitochondria were isolated by differential centrifugation as described previously 5, 6, [41] [42] [43] [44] [45] [46] and the mitochondria (0.5 mg protein/mL) were suspended in respiration buffer containing 130 mM KCl, 5 mM K 2 HPO 4 , 20 mM MOPS, 40 mM EGTA (carried over from the isolation buffer), 1 mM Na 4 P 2 O 7 , 0.1% BSA, pH 7.15 adjusted with KOH. To test mitochondrial viability and function, the RCI (state 3/state 4) was determined under different substrate conditions: Na-pyruvate (P, 10 mM) or Na-succinate (S, 10 mM) or S + rotenone (R, 4 mM). State 3 respiration was determined after adding 250 mM ADP. In other experiments using the same mitochondrial pellet, CRC was evaluated by measuring the decline in buffer [Ca 2+ ] with Fura-4 penta-K + using fluorescence spectrophotometry (QM-8, Horiba/Photon Technology International, PTI) as described previously [44] [45] [46] [47] [48] during bolus additions of 20 mM CaCl 2 every 90 seconds. Based on the similar improvement in cardiac function by individual or combined agonists, only the mitochondrial effects of the combined agonists NS1619 and DCEB were examined in the respiration and CRC experiments.
Statistical Analyses of Heart and Mitochondrial Data
Data obtained from hearts and mitochondria were expressed as mean 6 standard error of means. Appropriate comparisons were made among groups that differed by a variable at a given condition or time. Statistical differences were measured across groups using data comparisons at 25 minutes before global or regional ischemia versus 120 of reperfusion (ex vivo and in vivo hearts). Mitochondria were isolated 20 minutes after reperfusion and data were collected within 2 hours of isolation. Differences among variables were determined by 2-way multiple analysis of variance for repeated measures (Statview and CLR anova software programs for Macintosh); if F tests were significant, appropriate post hoc tests (eg, Student-Newman-Keul's) were used to compare means. Mean values were considered significant at P values (2-tailed) ,0.05. Fig. 1, IR) , whereas % infarct size was markedly increased (Fig. 2, IR) . After perfusion of hearts with the agonists and antagonists, we found that (1) DCEB or NS1619 alone was equally protective as was combining NS1619 + DCEB on developed LVP ( approximately inversely proportional to their effects on infarct size (Fig. 2) . Spontaneous heart rate before ischemia was approximately 240 beats/min in TCs and before ischemia. Heart rate, LVP, and infarct size were not affected by perfusion of any of the drugs before IR injury; heart rate and coronary flow returned to control values during the reperfusion phase in all groups. We then tested whether the BK Ca and SK Ca agonists and antagonists had any effects on the heart when delivered intravenously before ischemia and during reperfusion. Rats were infused with vehicle, PAX, NS8593, or PAX + NS8593, or with NS1619 or DCEB, before and after regional ischemia (LAD occlusion). Infarct size (% areaat-risk) was assessed after 120 minutes of reperfusion (Fig. 3) . There was no significant infarction in the sham animals and the infusion of drugs did not alter LVP or heart rate (data not shown) before IR. NS8593 or PAX infused alone enhanced infarct size, whereas simultaneous infusion of both NS8593 and PAX additionally enhanced infarct size; infusion of either NS1619 or DCEB reduced infarct size.
RESULTS
Global Protection by BK
Overall, these heart experiments demonstrated endogenous SK Ca and BK Ca channel activation in vivo rat hearts based on their antagonists' effects to enhance regional infarct size as well as endogenous BK Ca channel activation in ex vivo Guinea pig hearts based on an additive effect of inhibiting both channels on contractile function. The experiments also established the selectivity of the respective antagonists to block their respective agonists, and the role of ROS in mediating the exogenous protection afforded by both BK Ca and SK Ca channel agonists.
Mitochondrial Respiration and mCa 2+ Uptake After IR Injury in Guinea Pig Ex Vivo Hearts Treated With BK Ca and SK Ca Agonists or Antagonists
Cardiac protection due to BK Ca and SK Ca channel opening may be mediated largely by effects on mitochondrial bioenergetics. Thus, we tested if combined BK Ca and SK Ca agonists improved oxidative phosphorylation assessed by respiration rates and RCI in cardiac mitochondria isolated 20 minutes after reperfusion and 35 minutes of global ischemia (Table 1 and Fig. 4 ). The agonists were given together because we observed equivalent effects with the single agonists in the hearts and because the agonists given together did (Fig. 4A) . Under each substrate condition, states 2 and 4 respiration (Table 1) were increased, and state 3 respiration was decreased in mitochondria isolated after 20 minutes of reperfusion and 35 minutes of ischemia (red tracing/bars) compared with no IR (TC, black tracing/bars) (Fig. 4A) ; thus, RCI was markedly reduced by 2-6 fold, indicating significant uncoupling of phosphorylation from oxidation ( (Fig. 4) . Using the same mitochondrial pellets, we also monitored mitochondrial structural integrity by challenging isolated mitochondria with boluses of 20 mM CaCl 2 added to the respiration buffer (Fig. 4B) until the capability to take up and sequester CaCl 2 (CRC) was exceeded so that mitochondria extrude Ca 2+ through the so-called mitochondrial permeability transition pore (mPTP). Representative traces of CRC in mitochondria energized under succinate + rotenone conditions are displayed (Fig. 4B, top left) with mean CRC's under the 3 substrate conditions during state 2 respiration (Fig. 4B) ; cumulative mitochondrial Ca 2+ uptake was reduced after IR injury because of early mPTP opening but was greater after hearts were treated with NS1619 and DCEB (Fig. 4B, red and blue tracings) . Total average mitochondrial Ca 2+ uptake before mPTP activation was greater when ex vivo hearts were perfused with NS1619 + DCEB before and after ischemia in mitochondria energized with any of the 3 substrate conditions (columns Fig. 4B ). This indicated that relatively uncoupled mitochondria have elevated mitochondrial Ca 2+ levels during and after IR as we have shown Fig. 5A ). The antagonists were given separately and together because we observed different effects of NS8593 when given alone or with PAX on cardiac function and infarct size (Figs. 1-3 ). Representative traces of O 2 consumption in mitochondria energized with succinate (Fig. 5A upper left) are displayed with mean RCI's under the 3 substrate conditions (Fig. 5A) . Similar to the data in Table 1 and Figure 4A for the agonist experiments, states 2 and 4 respiratory rates were increased, and state 3 respiration was decreased in mitochondria isolated after ischemia and 20 minutes of reperfusion (red tracing/bars) compared with no IR (TC, black tracing/bars) ( Table 2 , Fig. 5A ). Treatment of hearts before and after IR with BK Ca and/or SK Ca antagonists PAX and NS8593 (green tracing/bar) did not worsen average RCI's (state 3/state 4) compared with IR alone under any substrate condition, which is different from the cardiac functional and tissue infarction results. This is not unexpected because the respiratory data are derived from an aggregate of functional and dysfunctional mitochondria retrieved during the isolation process and the variability of respiratory measurements may be insufficient to distinguish differences.
Using the same mitochondrial pellets isolated after IR injury, we again monitored mitochondrial structural integrity by challenging isolated mitochondria with boluses of 20 mM CaCl 2 (Fig. 5B) . Treatment with the combination of PAX and NS8593 slightly reduced CRC in mitochondria energized with pyruvate or succinate, but not with succinate + rotenone, when compared with IR alone. The reduced CRC after combined BK Ca and SK Ca antagonist treatment during IR corroborates the results on cardiac functional and tissue infarction.
DISCUSSION
Our results demonstrate that intrinsic activation of BK Ca and SK Ca channels provides endogenous cardiac functional protection (Fig. 1B) in the ex vivo cardiac global IR model on the basis of lowered developed LVP in the presence of PAX alone, and more so in the presence of PAX + NS8593 versus IR alone; however, only the presence of PAX enhanced global infarct size (Fig. 2B) . By contrast, in the in vivo model of regional IR injury (Fig. 3) , regional infarct size was larger in the presence of either PAX or NS8593 and even larger with infusion of both PAX and NS8593. The specific agonists for the BK Ca and the SK Ca channels, NS1619 and DCEB, provided equivalent protection against IR injury without additive effects. Our protocol for the isolated heart experiments was different from that used in our previous studies in which the BK Ca and SK Ca agonists were given only briefly to trigger PPC and the antagonists were given to prevent PPC. 4, 18 The finding that NS8593 alone did not enhance infarct size in the ex vivo global ischemia model channel antagonists NS8593 6 PAX given 20 minutes before and for 20 minutes after ischemia. RCI = state 3/state 4. TC hearts were not subject to ischemia but 75 minutes perfusion. Note that the lower RCI's after IR were not significantly lower after hearts were treated with PAX 6 NS8593 compared with IR alone with any substrate. n = hearts/group with 3-4 replicates within each mitochondrial pellet. P , 0.05. *IR + drugs versus IR only. †IR 6 drugs versus TC. See also Figure 4A .
as it did in the in vivo LAD occlusion model could be related to many factors, including differences in species, anesthetics given, collateral flow, potential for ischemic or anesthetic preconditioning, methods of inducing ischemia, and drug delivery. Nevertheless, the present results suggest that opening or preventing the opening of these K + channels leads to protective or antiprotective effects, respectively, through a common downstream mediator that is likely mitochondrial generated superoxide (O 2 $2 ) as observed by the loss of protection in the presence of TBAP (Figs. 1E, 2E) .
In combination, the BK Ca and the SK Ca channel agonists NS1619 and DCEB did not provide additional protection, unlike the combined antagonists that worsened function ex vivo and enhanced infarct size in vivo. This may indicate that providing either agonist exogenously provides maximal protection, whereas both channels are endogenously important in reducing IR injury. Because the mitochondrial targeted O 2 $2 scavenger, TBAP, given before and after ischemia, abrogated the functional recovery and the magnitude of infarction by both agonists alone or in combination, this suggested that the protection was mediated in large part by a mitochondrial effect to stimulate O 2 $2 generation. This was further supported not only by effects of BK Ca and SK Ca agonists to improve oxidative phosphorylation (RCI) and retain excess mCa 2+ (CRC) (Fig. 4) but also by effects of BK Ca and SK Ca antagonists to reduce Ca 2+ loading after IR injury (Fig. 5) . Overall, our novel observations suggest an important role for IR-induced BK Ca and SK Ca channel activation in FIGURE 5 . Effect of no treatment (TC, no I/R), IR only, or IR + BK Ca channel antagonist PAX 6 SK Ca channel antagonist NS8593, in 20 isolated guinea pig hearts on respiration (A) and CRC (B) in mitochondria isolated after 20 minutes reperfusion from groups described in Figures 1, 2 . The rate of O 2 consumption (respiration) was measured when substrate was added (state 2), followed by ADP (state 3) and after the added ADP was consumed (state 4); substrates added were pyruvate, succinate, or succinate + rotenone (Table 2) ; state 3/ state 4 ratio is defined as the RCI. Uptake of external Ca 2+ was assessed (Fura-4 fluorescence) in mitochondria energized under the same 3 substrate conditions; increased number of 20 mM CaCl 2 injections (pulses) = increased CRC. Note that the decreased RCI with IR only was not different after treatment with the BK Ca and/or SK Ca antagonists; by contrast, CRC was reduced after treatment with the BK Ca and/or SK Ca antagonists in the presence of pyruvate or succinate. For each group n = 4; RCI and CRC were measured from same mitochondrial pellet from each heart. *P , 0.05.
cardiomyocyte mitochondria in providing endogenous protection against IR injury as observed by treatment of hearts with either or both channel antagonists.
BK Ca and SK Ca Channel Agonists Reduce and Antagonists Enhance Cardiac IR Injury Through a Mitochondrial Mechanism
Individually, BK Ca and SK Ca channels seem to be important for protecting against cardiac myocyte damage during oxidative stress. 4, 18, 26, [50] [51] [52] [53] Allowing for possible nonspecific effects of the agonists and antagonists, our data furnish support that pharmacologic opening of either BK Ca or SK Ca channels is cardioprotective. Moreover, intrinsic activation of BK Ca or SK Ca channels, and especially when activated together, may be essential for endogenous protection against IR injury. By contrast, because there were no additive effects of the 2 agonists (Figs. 1A, 2A) , protection by either of these agonists may have provided maximal protection through a mK + uptake mechanism.
In our experiments, the antagonists were given before, during, and after ischemia to test for possible endogenous cardioprotection. Because of different K + channel characteristics and endogenous protective effects, we speculate that mSK Ca channels open gradually under conditions in which DC m becomes reduced, pH m becomes progressively lower, and matrix Ca 2+ progressively rises, as occurs during ischemia. By contrast, mBK Ca channel opening may occur when DC m rebounds, cytosolic Ca 2+ surges, and pH m is high, as during initial reperfusion. This purported timing of opening of these channels, although likely over-simplified, is based on our studies of changes in redox state (NAHD, FAD), diastolic, systolic, and mitochondrial matrix [Ca 2+ ], and cytosolic [Na + ] during the time course of cardiac IR injury. 27, [54] [55] [56] [57] [58] Importantly, the BK Ca and SK Ca channel agonists and antagonists were bioactive when infused intravenously, as evidenced by the differences in cardiac infarct size after LAD occlusion in the in vivo rat model (Fig. 3 ). This suggests a translational value for potential intravenous treatment of K Ca channel agonists during cardiac IR injury in humans. In fact, we have recently identified splice variants of the SK Ca channel in human ventricular myocytes, 26 which warrants development of SK Ca -targeted therapeutic strategies for human cardiac IR injury.
The isolated heart and animal studies could not indicate specifically where the anti-and pro-cardioprotective effects of BK Ca and SK Ca antagonist and agonists, respectively, occur, ie, in mitochondria versus other cellular sites such as the sarcolemma. However, pharmacologic evidence for a role of mitochondrial BK Ca and SK Ca channels is given by the improved or worsened RCI's and CRC's (Figs. 4A, B versus Figs. 5A, B) in isolated guinea pig mitochondria after ex vivo IR injury in the presence of SK Ca and BK Ca agonists/antagonists. That the protection is mediated at the mitochondrial level is further supported by the effect of the free radical scavenger TBAP to abolish cardioprotection (Figs. 1E, 2E ). This is because the respiratory complexes of the mitochondrial electron transport chain are most likely the major source of signaling ROS for cytoprotection and deleterious excess ROS production during IR injury. 1 Indeed, both BK Ca 50 and SK Ca 18, 26 channels are located in cardiac cell IMM rather than in the sarcolemmal membrane, and drug-induced opening of the BK Ca channel in isolated mitochondria leads to mild ROS production without significantly affecting DC m . 6 We believe that this small amount of O 2 $2 emitted is important for signaling mechanisms that confer protection during treatment with a BK Ca or SK Ca agonist.
Distribution and Function of Ca 2+ -sensitive K + Channels
The cell membranes of vascular smooth muscle, neural, and secretory cells contain large conductance (200-300 pS, ie, Big Ca 2+ -sensitive K + (BK Ca , aka maxi-K Ca ) channels that when activated produce vasodilation, hyperpolarization, and secretion in these cells, respectively. BK Ca channel opening is activated by increased cytosolic [Ca 2+ ] and by a large voltage gradient. 59 Activation of BK Ca channels over a range of [Ca 2+ ] is mediated at several binding sites within the channel 60 so that there is a wide range of [Ca 2+ ] responsiveness (K a 10-1000 mM). 61 As K + exits the cell with BK Ca channel opening, this elicits cell membrane repolarization or hyperpolarization, which in turn reduces cell Ca 2+ entry by closing voltage-dependent Ca 2+ channels. The finding of altered redox potential in smooth muscle cells 62 suggested that there was a mitochondrial involvement. Indeed, Xu et al 50 provided the first evidence that BK Ca channels are prominently located in cardiac mitochondria. By contrast, SK Ca channels are not voltage dependent and their agonists interact with their Ca 2+ sensor calmodulin in the C-terminus region; however, at least for NS8593, the SK Ca -mediated gating modulation occurs through interaction with gating structures near the selectivity filter within the inner pore vestibule. 24 Studies of effects of BK Ca and SK Ca channel opening in cell membranes might help to assess the mechanisms of protection by their counterparts that reside in the IMM. For example, BK Ca channels are proposed to regulate cell membrane potential in neurons. 63 SK Ca channels in neurons lie adjacent to Ca 2+ stores and Ca 2+ channels to sense Ca 2+ activated K + flux. 64 Neuronal SK Ca channels seem to play a role in setting the intrinsic firing frequency, whereas neuronal BK Ca channels may regulate action potential shape. 15 SK Ca channels are also located in neuronal (hippocampus-derived cells) mitochondria where they seem to provide protection against excitotoxicity. 17 BK Ca -and SK Ca -mediated K + flux in mitochondria may be differentiated by the number of channels/surface area, sensitivity to Ca 2+ , and dependence on DC m during mitochondrial respiration. Because there are several differences in the triggers for activating these channels, the functional effects of opening these channel may be different; eg, unlike for BK Ca , SK Ca channel opening may "fine tune" matrix K + influx because of changing matrix Ca 2+ levels independent of changes in DC m during the variable rate of oxidative phosphorylation. The presence of SK Ca channels specifically in the IMM 18 6 We have suggested, moreover, 65 that an increase in intramatrix K + is replaced over time with H + through mKHE and that at low concentrations, these openers produce a transient increase in matrix acidity, ie, in which the proton leak stimulates respiration but maintains DC m so that signaling O 2 $2 is generated at mitochondrial respiratory complexes because of accelerated electron transport. Therefore, during the periods of ischemia and reperfusion, mK + influx, due to condition-dependent activation of SK Ca 27, 49 During IR injury, the rise in cytosolic and in m[Ca 2+ ] likely triggers mK + influx by mBK Ca and mSK Ca channel activation to initially induce matrix swelling as a potential protective mechanism. Alternatively, or in addition, H + influx through mKHE may enhance respiration to maintain ΔC m but also induce signaling levels of O 2 $2 (cartoon, Fig. 6 ). We observed that PAX, NS1619, and PAX + NS8593 treatments reduced the increase in pyruvate-mediated state 2 respiration found after IR alone, but increased the succinate-mediated state 2 respiration compared with IR alone (Table 2) . This implies that endogenous mK Ca channel activation does lead to mild uncoupling through mKHE during succinate but not during pyruvate consumption. It is also possible that K + is required for optimal functioning of oxidative phosphorylation because mK + flux largely regulates mitochondrial volume that in turn may modulate bioenergetics. [72] [73] [74] Thus mSK Ca channels, like mBK Ca channels, 50, 75 may also act to modulate mitochondrial volume during the increase in matrix Ca 2+ loading that occurs during ischemia and more so on reperfusion. 27, 31 Xu et al 50 suggested that opening mBK Ca channels to enhance matrix K + influx mitigates IR injury in a manner similar to putative mK ATP channel opening. They proposed 50 that the function of mBK Ca channels was to improve the efficiency of mitochondrial energy production. In addition to mBK Ca and mSK Ca channels, and the putative mK ATP channels, 72, [75] [76] [77] [78] [79] another K + channel, the Na + -activated K + channel, SLO2, 80, 81 has been reported to be located in mitochondria; this channel is also cytoprotective, at least in part due to activation of mK + influx. Thus, although the mK + channel sensing conditions may be different, the net effect of mK + influx, increases in mitochondrial volume and/or mH + through mKHE, seems to be the same. Because mK Ca channels likely play a major role in regulating mitochondrial bioenergetics by modulating ion flux, it is unclear exactly how opening of these channels leads to higher NADH/FAD ratios and decreases in excess ROS and in Ca 2+ overload during IR. For the presumptive mK ATP channel, it was proposed that its opening depolarizes the IMM and decreases mCa 2+ overload. 75, 76, 82 It should be noted that Garlid's group 72, 83 has proposed that the physiological role of mK + channel opening is control of mitochondrial volume rather than dissipation of DC m and uncoupling, because swelling induced by mK + uptake (without mKHE) would occur with concomitant uptake of Cl 2 and subsequently water by osmosis. They suggested that subsequent activation of mKHE would only slightly dissipate the proton motive gradient (ΔmH) by increasing matrix acidity (H + leak) without significantly altering DC m . 73, 83 We found that NS1619 resulted in an increase in mK + uptake, but only in the presence of quinine, a nonspecific KHE blocker 65 ; this suggested that mKHE promoted mK + efflux over time. However, our results also indicated that mpH was lower when quinine was present; this led to the suggestion that mH + influx induced by NS1619 was not exclusively through mKHE and that NS1619 may also directly or indirectly act as a protonophore. Moreover, valinomycin-induced mK + influx exerted a biphasic effect, ie, to alkalinize and then to acidify the matrix. 65 Thus the mechanism and timing remain unclear. What does seem apparent is that either agonist of mK Ca channels leads to improved mitochondrial bioenergetics, with reduced mCa 2+ overload and ROS production, which thereby provides overall substantial mitochondrial and myocyte protective effects during cardiac IR injury ex vivo and reduced infarct size ex vivo and in vivo.
Based on limited experimental observations and some speculation, there are several possible scenarios of potential mechanisms for mBK Ca and mSK Ca activation and effectors that lead to cardiac protection (cartoon, Fig. 7) . In scenario A, as reperfusion restores cytosolic pH, this promotes excess cytosolic Ca 2+ loading by sarcolemal NHE and NCE, which then causes excess mCa 2+ loading with DC m repolarization; in turn this activates mK + influx predominately through mBK Ca but also through mSK Ca channels due to increased mCa 2+ . In scenario B, as ischemia ensues, an increase in the IMM chemical gradient for Ca 2+ enhances mCa 2+ uptake when DC m and cell pH are lower; this induces mK + influx predominately through SK Ca channels but also through BK Ca channels due to increased cyctosolic Ca 2+ ; through either pathway mK + influx is countered by activation of mKHE that acidifies the matrix and promotes uncoupling (higher respiration). In scenario C, independent increases of either cell or mCa 2+ , induced under conditions of ischemia or reperfusion, stimulates mK + influx independently through mBK Ca and mSK Ca channels. In each scenario, uncoupling through mKHE leads to reversal of the increase in mitochondrial volume and generation of small amounts of signaling O 2 $2 . In each scenario, if the matrix signaling O 2 $2 generated by uncoupling were rapidly dismutated to H 2 O 2 by TBAP, the protection would be lost because downstream ROS-dependent protective pathways would not be activated. We suggest that scenario B may best explain the utility of independent activation of either type of mK Ca channel during ischemia and during reperfusion that together protect against cardiac IR injury. This is because we observed that the antagonists together exerted some additive endogenous antiprotective effects that likely depend on the different biochemical conditions that occur during ischemia and during reperfusion. A, BK Ca channels might be rapidly activated during reperfusion just after ischemia when DC m rapidly becomes fully charged and there is a surge in cytosolic and concomitantly an increase in mitochondrial [Ca 2+ ]. Independently, SK Ca channels might be activated more slowly during ischemia when mitochondrial matrix [Ca 2+ ] progressively rises in association with the lower DC m and pH m during ischemia. B, In this scenario, BK Ca and SK Ca channels might function rather independently to enhance K + influx and trigger KHE, cause mild uncoupling, and induce small amounts of signaling ROS. C, In another alternative pathway, net mK + influx because of SK Ca channel opening might be affected by simultaneous BK Ca channel opening to alter either the matrix volume or the degree of mKHE-induced uncoupling. or each possibility, signaling levels of ROS would need to be produced as a result of mK + influx to initiate cardiac protection. A = additive or single pathway, B = parallel pathways with convergence, and C = parallel pathways with different mechanisms.
SUMMARY AND LIMITATIONS
We have furnished comparative evidence for cardiac protective effects of BK Ca and SK Ca channel agonists and counter protective effects of BK Ca and SK Ca channel antagonists with demonstrated specificity of the antagonists to hinder protection by the agonists. Moreover, systemic application of the agonists and antagonists appears efficacious and deliterious, respectively, and suggests therapeutic potential for agonist treatment in humans. The end effect of mK + channel opening in cardiac mitochondria seems to be a respiration dependent pathway that stimulates a small amount of signaling mitochondrial O 2 $2 that leads to cardioprotection by downstream and local mitochondrial mechanisms as shown by drug treatments on mitochondrial respiration and mCa 2+ uptake. However, there is as yet little delineation of the individual stages and timing of triggering, activation, and end-effects of mK + channel opening. Unraveling this apparently complicated, and potentially redundant, mechanism that culminates in cardiac protection could lead to therapeutic approaches for protection, specifically through a mitochondrial-targeted mechanism. However, an efficacious therapy would likely require targeting of specific cardiac mitochondrial splice variants of mK Ca channels, so that the function of other BK Ca and SK Ca channels in other organs and subcellular sites would not be impinged.
